215 related articles for article (PubMed ID: 22717644)
1. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
[TBL] [Abstract][Full Text] [Related]
2. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
Papandreou D; Karabouta Z; Pantoleon A; Rousso I
Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
[TBL] [Abstract][Full Text] [Related]
3. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E.
D'Adamo E; Marcovecchio ML; Giannini C; de Giorgis T; Chiavaroli V; Chiarelli F; Mohn A
Free Radic Res; 2013 Mar; 47(3):146-53. PubMed ID: 23205728
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
Reinehr T; Schmidt C; Toschke AM; Andler W
Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
[TBL] [Abstract][Full Text] [Related]
5. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
Radetti G; Kleon W; Stuefer J; Pittschieler K
Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
[TBL] [Abstract][Full Text] [Related]
8. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
[TBL] [Abstract][Full Text] [Related]
9. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
10. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
11. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
Reinehr T; Woelfle J; Wunsch R; Roth CL
J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
[TBL] [Abstract][Full Text] [Related]
13. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA
Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
16. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P
Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
[TBL] [Abstract][Full Text] [Related]
17. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
18. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.
Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
J Pediatr Endocrinol Metab; 2012; 25(9-10):927-34. PubMed ID: 23426822
[TBL] [Abstract][Full Text] [Related]
19. [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai].
Wan YP; Xu RY; Fang H; Lu LP; Zhang XM; Cai W
Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):644-8. PubMed ID: 17903363
[TBL] [Abstract][Full Text] [Related]
20. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
Pirgon O; Bilgin H; Tolu I; Odabas D
Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
